Our results showed that shRNA-mediated SALL4 inhibition induced the loss of stemness in ESCC cells through decreasing the expression levels of Sox2, Oct4 and Nanog, which was in agreement with previous studies. This evidence concerns the gene SALL4 and esophageal squamous cell carcinoma.